<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37127712</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3106</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Advances in rheumatology (London, England)</Title><ISOAbbreviation>Adv Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study.</ArticleTitle><Pagination><StartPage>20</StartPage><MedlinePgn>20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42358-023-00297-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Several studies have compared the clinical features and outcomes of late- and early-onset systemic lupus erythematosus (SLE) patients. However, these previous studies were uncontrolled. The current study aimed to compare late- and early-onset SLE patients while controlling for sex and year at diagnosis (&#xb1;&#x2009;1 year).</AbstractText><AbstractText Label="METHODS">The medical records of SLE patients in a lupus cohort from January 1994 to June 2020 were reviewed. Late-onset patients were identified as those with an age at diagnosis&#x2009;&#x2265;&#x2009;50 years. The early-onset patients (age at diagnosis&#x2009;&lt;&#x2009;50 years) were matched by sex and year at diagnosis with the late-onset patients at a ratio of 2:1. Clinical manifestations, disease activity (mSLEDAI-2K), organ damage scores, treatment, and mortality were compared between the two groups.</AbstractText><AbstractText Label="RESULTS">The study comprised 62 and 124 late- and early-onset patients, respectively, with a mean follow-up duration of 5 years. At disease onset, when comparing the early-onset patients with the late-onset patients, the latter group had a higher prevalence rate of serositis (37.0% vs. 14.5%, p&#x2009;&lt;&#x2009;0.001) and hemolytic anemia (50.0% vs. 33.9%, p&#x2009;=&#x2009;0.034) but lower prevalence rate of malar rash (14.5% vs. 37.1%, p&#x2009;=&#x2009;0.001), arthritis (41.9% vs. 62.1%, p&#x2009;=&#x2009;0.009), leukopenia (32.3% vs. 50.0%, p&#x2009;=&#x2009;0.022) and lymphopenia (50.0% vs. 66.1%, p&#x2009;=&#x2009;0.034). The groups had similar SLE disease activity (7.41 vs. 7.50), but the late-onset group had higher organ damage scores (0.37 vs. 0.02, p&#x2009;&lt;&#x2009;0.001). The rates of treatment with corticosteroids, antimalarial drugs, or immunosuppressive drugs were not different. At their last visit, the late-onset patients still had the same pattern of clinically significant differences except for arthritis; additionally, the late-onset group had a lower rate of nephritis (53.2% vs. 74.2%, p&#x2009;=&#x2009;0.008). They also had a lower level of disease activity (0.41 vs. 0.57, p&#x2009;=&#x2009;0.006) and received fewer antimalarials (67.7% vs. 85.5%, p&#x2009;=&#x2009;0.023) and immunosuppressive drugs (61.3% vs. 78.2%, p&#x2009;=&#x2009;0.044), but they had higher organ damage scores (1.37 vs. 0.47, p&#x2009;&lt;&#x2009;0.001) and higher mortality rates/100-person year (3.2 vs. 1.1, p&#x2009;=&#x2009;0.015). After adjusting for disease duration and baseline clinical variables, the late-onset patients only had lower rate of nephritis (p&#x2009;=&#x2009;0.002), but still received fewer immunosuppressive drugs (p&#x2009;=&#x2009;0.005) and had a higher mortality rate (p&#x2009;=&#x2009;0.037).</AbstractText><AbstractText Label="CONCLUSIONS">In this sex- and year at diagnosis-matched controlled study, after adjusting for disease duration and baseline clinical variables, the late-onset SLE patients had less renal involvement and received less aggressive treatment, but had a higher mortality rate than the early-onset patients.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mongkolchaiarunya</LastName><ForeName>Jarukit</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wongthanee</LastName><ForeName>Antika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasitanon</LastName><ForeName>Nuntana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louthrenoo</LastName><ForeName>Worawit</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3105-6122</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. worawit.louthrenoo@cmu.ac.th.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Rheumatol</MedlineTA><NlmUniqueID>101734172</NlmUniqueID><ISSNLinking>2523-3106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000721270">malar rash</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="Y">Arthritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009393" MajorTopicYN="Y">Nephritis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical manifestations</Keyword><Keyword MajorTopicYN="N">Late-onset</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37127712</ArticleId><ArticleId IdType="doi">10.1186/s42358-023-00297-0</ArticleId><ArticleId IdType="pii">10.1186/s42358-023-00297-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dall&#x2019;Era M, Wofsy D. Clinical features of systemic lupus erythematosus. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O&#x2019;Dell JR, editors. Kelley &amp; Furestein&#x2019;s Textbook of Rheuamtology. Volume 2. Philadelphia: Elsevier; 2017. pp. 1345&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-31696-5.00080-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). 2012;64(2):159&#x2013;68. https://doi.org/10.1002/acr.20683 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20683</ArticleId><ArticleId IdType="pubmed">22052624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce IN, O&#x2019;Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic Lupus International collaborating clinics (SLICC) inception cohort. Ann Rheum Dis. 2015;74(9):1706&#x2013;13. https://doi.org/10.1136/annrheumdis-2013-205171 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-205171</ArticleId><ArticleId IdType="pubmed">24834926</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribe AG, Alarcon GS. Ethnic disparities in patients with systemic lupus erythematosus. Curr Rheumatol Rep. 2003;5(5):364&#x2013;9. https://doi.org/10.1007/s11926-003-0022-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-003-0022-8</ArticleId><ArticleId IdType="pubmed">12967518</ArticleId></ArticleIdList></Reference><Reference><Citation>Boodhoo KD, Liu S, Zuo X. Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Med (Baltim). 2016;95(29):e4272. https://doi.org/10.1097/MD.0000000000004272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongkoltanatus J, Wangkaew S, Kasitanon N, Louthrenoo W. Clinical features of Thai male lupus: an age-matched controlled study. Rheumatol Int. 2008;28(4):339&#x2013;44. https://doi.org/10.1007/s00296-007-0442-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-007-0442-2</ArticleId><ArticleId IdType="pubmed">17828538</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012;39(4):759&#x2013;69. https://doi.org/10.3899/jrheum.111061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.111061</ArticleId><ArticleId IdType="pubmed">22382348</ArticleId><ArticleId IdType="pmc">3605704</ArticleId></ArticleIdList></Reference><Reference><Citation>Appenzeller S, Pereira DA, Costallat LT. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus. 2008;17(11):1023&#x2013;8. https://doi.org/10.1177/0961203308089695 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308089695</ArticleId><ArticleId IdType="pubmed">18852227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn IW, Joo YB, Won S, Bae SC. Late-onset systemic lupus erythematosus: is it &#x201c;mild lupus&#x201d;? Lupus. 2018;27(2):235&#x2013;42. https://doi.org/10.1177/0961203317716789 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317716789</ArticleId><ArticleId IdType="pubmed">28650278</ArticleId></ArticleIdList></Reference><Reference><Citation>Catoggio LJ, Soriano ER, Imamura PM, Wojdyla D, Jacobelli S, Massardo L et al. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Lupus. 2015;24(8):788&#x2013;795. https://doi.org/10.1177/0961203314563134</Citation></Reference><Reference><Citation>Aljohani R, Gladman DD, Su J, Urowitz MB. Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus. 2017;26(11):1190&#x2013;6. https://doi.org/10.1177/0961203317696593 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317696593</ArticleId><ArticleId IdType="pubmed">28420066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalani S, Pope J, de Leon F, Peschken C, Members of Ca NFoL. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol. 2010;37(1):38&#x2013;44. https://doi.org/10.3899/jrheum.080957 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080957</ArticleId><ArticleId IdType="pubmed">20008925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoli AM, Alarcon GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 2006;54(5):1580&#x2013;7. https://doi.org/10.1002/art.21765 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21765</ArticleId><ArticleId IdType="pubmed">16645994</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Park DJ, Kang JH, Yim YR, Lee KE, Lee JW, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in korean patients. Lupus. 2015;24(12):1342&#x2013;9. https://doi.org/10.1177/0961203315591024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315591024</ArticleId><ArticleId IdType="pubmed">26085595</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng JB, Ni JD, Yao X, Pan HF, Li XP, Xu JH, et al. Gender and age influence on clinical and laboratory features in chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int. 2010;30(8):1017&#x2013;23. https://doi.org/10.1007/s00296-009-1087-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-009-1087-0</ArticleId><ArticleId IdType="pubmed">19701756</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartella S, Cavazzana I, Ceribelli A, Inverardi F, Tincani A, Franceschini F. Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic lupus erythematosus. Autoimmunity. 2013;46(6):363&#x2013;8. https://doi.org/10.3109/08916934.2013.794793 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2013.794793</ArticleId><ArticleId IdType="pubmed">23706114</ArticleId></ArticleIdList></Reference><Reference><Citation>Riveros Frutos A, Holgado S, Sanvisens Berge A, Casas I, Olive A, Lopez-Longo FJ, et al. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford). 2021;60(4):1793&#x2013;803. https://doi.org/10.1093/rheumatology/keaa477 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa477</ArticleId><ArticleId IdType="pubmed">33106841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassi RH, Hendler JV, Piccoli GF, Gasparin AA, da Silva Chakr RM, Brenol JC, et al. Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus. Clin Rheumatol. 2017;36(1):89&#x2013;95. https://doi.org/10.1007/s10067-016-3478-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3478-4</ArticleId><ArticleId IdType="pubmed">27858177</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddaert J, Huong DLT, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Med (Baltim). 2004;83(6):348&#x2013;59. https://doi.org/10.1097/01.md.0000147737.57861.7c .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000147737.57861.7c</ArticleId></ArticleIdList></Reference><Reference><Citation>Medhat BM, Behiry ME, Sobhy N, Farag Y, Marzouk H, Mostafa N, et al. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort. Clin Rheumatol. 2020;39(2):435&#x2013;42. https://doi.org/10.1007/s10067-019-04776-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04776-y</ArticleId><ArticleId IdType="pubmed">31758421</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak SK, Lam EK, Wong AK. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus. 1998;7(1):23&#x2013;8. https://doi.org/10.1191/096120398678919723 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120398678919723</ArticleId><ArticleId IdType="pubmed">9493145</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol. 2002;29(5):913&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12022349</ArticleId></ArticleIdList></Reference><Reference><Citation>Merola JF, Bermas B, Lu B, Karlson EW, Massarotti E, Schur PH, et al. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014;23(8):778&#x2013;84. https://doi.org/10.1177/0961203314526291 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314526291</ArticleId><ArticleId IdType="pubmed">24608964</ArticleId><ArticleId IdType="pmc">4157121</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevete I, Iuliano A, Cauli A, Piga M, Iannone F, Coladonato L, et al. Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus. Clin Exp Rheumatol. 2022. https://doi.org/10.55563/clinexprheumatol/oo5ymg .</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/oo5ymg</ArticleId><ArticleId IdType="pubmed">35894063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. https://doi.org/10.1002/art.1780400928 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271&#x2013;7. https://doi.org/10.1002/art.1780251101 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS. The systemic lupus activity Measure-revised, the mexican systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31(10):1934&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">15468356</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the systemic Lupus International collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363&#x2013;9. https://doi.org/10.1002/art.1780390303 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780390303</ArticleId><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index Lupus. 1999;8(6):462&#x2013;5. https://doi.org/10.1177/096120339900800609 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339900800609</ArticleId><ArticleId IdType="pubmed">10483015</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeleniewicz R, Suszek D, Majdan M. Clinical picture of late-onset systemic lupus erythematosus in a group of polish patients. Pol Arch Med Wewn. 2015;125(7&#x2013;8):538&#x2013;44. https://doi.org/10.20452/pamw.2963 .</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.2963</ArticleId><ArticleId IdType="pubmed">26075796</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso MD, Martinez-Vazquez F, de Teran TD, Miranda-Filloy JA, Dierssen T, Blanco R, et al. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus. 2012;21(10):1135&#x2013;48. https://doi.org/10.1177/0961203312450087 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203312450087</ArticleId><ArticleId IdType="pubmed">22652632</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray RW, May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum. 2003;48(8):2100&#x2013;10. https://doi.org/10.1002/art.11105 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11105</ArticleId><ArticleId IdType="pubmed">12905462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CT, Mok CC, Lau CS, Wong RW. Late onset systemic lupus erythematosus in southern chinese. Ann Rheum Dis. 1998;57(7):437&#x2013;40. https://doi.org/10.1136/ard.57.7.437 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.57.7.437</ArticleId><ArticleId IdType="pubmed">9797573</ArticleId><ArticleId IdType="pmc">1752656</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhoo A, Mody GM, Dubula T, Patel N, Mody PG. Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus. Lupus. 2017;26(4):438&#x2013;46. https://doi.org/10.1177/0961203316676380 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316676380</ArticleId><ArticleId IdType="pubmed">27837197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak A, Cheung MW, Chiew HJ, Liu Y, Ho RC. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41(6):830&#x2013;9. https://doi.org/10.1016/j.semarthrit.2011.11.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2011.11.002</ArticleId><ArticleId IdType="pubmed">22257558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus. 2016;25(7):727&#x2013;34. https://doi.org/10.1177/0961203315627202 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315627202</ArticleId><ArticleId IdType="pubmed">26811368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>